Current Edition

CMV

Takeda wins US approval for new CMV treatment

Livtencity is part of the first wave of new products Takeda hopes will reposition the company as a top player in the pharmaceutical industry for …

Continue Reading →
FDA

Takeda wins FDA approval for targeted lung cancer drug

In the midst of a years-long makeover, Takeda is looking to new products such as Exkivity to shore up future growth and cement its place …

Continue Reading →